BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 12672036)

  • 1. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China.
    Wang B; Mi M; Wang J; Wei N; Zhang Q; Zhu J; Yang S; Guo B; Xu J; Yang X
    Int J Cancer; 2009 Apr; 124(8):1892-9. PubMed ID: 19117053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
    Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
    Key T; Appleby P; Barnes I; Reeves G;
    J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
    Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
    J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
    Tworoger SS; Zhang X; Eliassen AH; Qian J; Colditz GA; Willett WC; Rosner BA; Kraft P; Hankinson SE
    J Clin Oncol; 2014 Oct; 32(28):3111-7. PubMed ID: 25135988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
    Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.